Lung Cancer Research News
New Hope for SCLC Patients
FDA-approved Tarlatamab will give patients with small cell lung cancer a new treatment option.
Together we can make a lasting impact
Your support is vital to our mission of funding transformative science and improving survivorship.
Recently diagnosed with lung cancer?
Learn more about your lung cancer diagnosis. What questions should you be asking? What are the most important next steps? Know that you have options and remember that knowledge is power.
Meet the Researchers
View All-
Jonathan Villena-Vargas, MD
Thoracic Surgeon
Characterizing T cell PD-1 response in the tumor-draining lymph nodes of early-stage NSCLC patients
-
Jacob Kaufman, Md, PhD
Medical Oncology
Understanding how the specific genetic background of each cancer affects their behaviors in patients
-
-
Research is HOPE. Research will hopefully have me sitting here in #GiveMe20. Give me 20 years post-diagnosis.
Brandi Bryant, living with lung cancer
-
Your generosity is shaping future leaders in lung cancer research.
Kim Norris, Co-Founder and President
-
There is such tremendous hope for all patients with lung cancer right now.
Dr. Christine Lovly, LCFA Young Investigator
Word of the Day
Blood count
A blood count refers to the measurement of various components of the blood, including red blood cells, white blood cells, and platelets. It can provide valuable information about a person’s overall health and help detect conditions such as anemia or infections, which are common in lung cancer patients.